Vaishali Pharma Ltd recommends 1:1 bonus issue and 1:5 stock split
The company is making its mark through strategic initiatives, promising to become a significant presence in the evolving pharmaceutical sector
The company is making its mark through strategic initiatives, promising to become a significant presence in the evolving pharmaceutical sector
Morepen Labs successfully raised Rs. 200 Crore through QIP
Acute therapies continue to report strong growth compared to chronic ones.
Subscribe To Our Newsletter & Stay Updated